Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« PIHKAL: A Book Review by David Nott | Main | 2005 Carnival of the Capitalists »

December 30, 2004

Smart Mobs of Neurocompetitors

Email This Entry

Posted by Zack Lynch

Smart Mobs picks up on a recent article in CIO that highlights the potential of using neurotechnology for competitive advantage.

Neurocompetitive advantage was the focus of recent talk I gave in Dubai at the Arab Strategy Forum. While the neurotechnology industry is currently being driven by the need for better treatments for brain-related illnesses, you can bet, that if there is a way to safely improve human capital productivity, individuals will them to compete and keep their jobs. (see neurofinance)

By enabling a higher level of productivity, neurotechnology represents the next form of competitive advantage beyond information technology.

Comments (0) + TrackBacks (0) | Category:



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20
Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
McGovern Institue for Brain Research at MIT Goes Web 2.0
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
Neuropharma FDA Approvals Down in 2009
Tel Aviv Neurotech Cluster Thrives